Product Liability and Mass Torts

Class Certification - Product Liability and Consumer Class Actions

Class Certification - Product Liability and Consumer Class Actions

Courts increasingly grant or deny class certification with the benefit of expert economic and statistical analysis. NERA experts are experienced in producing rigorous empirical analyses to assess whether Rule 23 requirements are met. We also regularly evaluate the analyses produced by opposing experts and assess whether they meet the Daubert criteria for admissibility.

Key Areas of Expertise

The analysis that is most helpful at the class certification stage may differ in personal injury class actions from no-injury class actions, and in cases alleging product defects from those involving misrepresentations of product features or performance. Empirical analysis -- using sales data, public demographic information, or the results of specially designed surveys -- can help inform the class certification inquiry in a wide range of product liability and consumer class actions.

Representations and Omissions

Class actions in product liability often involve claims of misrepresentations, omissions, and deceptive marketing practices. In these instances, key issues at the class certification stage can include establishing how consumers interpreted key communications, whether those communications were material to their decisions, and whether they relied upon the alleged misinformation in making a decision. If differences are found across consumers in their exposure and reliance on representations, it undermines the proposition that the impact of the misrepresentation can be proven for all class members using common evidence (Rule 23(b)(3)). NERA experts have experience in evaluating the extent to which alleged omissions and misrepresentations may be the basis for defining a class.

Potential Defect Rates

Product liability class actions often start when a product failure or defect is identified. Such failures give rise to potential claims of a systemic problem or "product defect." In such instances, statistical analysis of samples of products can help establish the extent to which a specific problem is closely linked with unique conditions or circumstances. NERA experts have experience in designing samples and analyzing product use and product failure data to identify relevant patterns.

Coherence of Proposed Class

Product liability class actions presume that an aggrieved pool of consumers exists who have experienced the alleged issue. In the precertification stage, a key analysis is whether the alleged putative class is properly defined. Questions frequently arise as to the size, socio-demographic characteristics, perceptions, and behaviors of various segments of any proposed class. Careful analysis of the putative class may identify how different circumstances or preferences may have affected experience with a product, raising commonality and typicality concerns or delineating potential subclasses. NERA experts work with a wide range of data sources and client records to understand the composition of putative classes.

Migration of Class Members between States

In class actions filed in state court, migration of class members across state lines raises problems for class certification. Migration analysis can quantify the extent of the relevant population's movement across states and is appropriate when the injuries of some class members may have been sustained in a state other than the one where the lawsuit has been filed. For example, migration analysis may be useful in pharmaceutical litigation where injuries develop over time. In this case, proposed class members could have taken the product while living in one state before moving to another state where the class is being formed. Migration analysis has most often been applied in cases involving health-related issues, but has also been successfully applied outside the setting of personal injury class actions.

To learn more, we invite you to read this overview of our capabilities in this area.

Name Title Location Phone Email
Lucy P. Allen Managing Director New York City +1 212 345 5913 lucy.allen@nera.com
Dr. Denise Neumann Martin Managing Director New York City +1 212 345 5296 denise.martin@nera.com
Dr. Faten Sabry Managing Director
Bankruptcy Practice Chair
New York City
London
+1 212 345 3285
+44 20 7659 8618
faten.sabry@nera.com
Dr. Kent Van Liere Managing Director Denver
San Francisco
+1 303 357 4782
+1 415 291 1010
kent.van.liere@nera.com
Mary Elizabeth C. Stern Director White Plains, NY +1 914 448 4054 mary.elizabeth.stern@nera.com
Drew Claxton Associate Director New York City +1 212 345 3442 drew.claxton@nera.com
Dr. Stephanie Plancich Associate Director New York City +1 212 345 7719 stephanie.plancich@nera.com
Dr. Eugene Ericksen Affiliated Academic Philadelphia +1 215 864 3878 eugene.ericksen.affiliate@nera.com
Title Type Author
Snapshot of Recent Trends in Asbestos Litigation: 2017 Update Report Mary Elizabeth C. Stern and Lucy P. Allen
Asbestos: Economic Assessment of Bans and Declining Production and Consumption Report By Lucy P. Allen, Mary Elizabeth C. Stern, Jorge Baez, and Frank George
Snapshot of Recent Trends in Asbestos Litigation: 2010 Update White Paper By Lucy P. Allen and Mary Elizabeth Stern
Snapshot of Recent Trends in Asbestos Litigation White Paper By Lucy P. Allen and Mary Elizabeth Stern
Use of Sample Surveys in Product Liability Litigation Published Article By Dr. Kent Van Liere